Research ArticleMalaria

An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria

See allHide authors and affiliations

Science Translational Medicine  20 May 2020:
Vol. 12, Issue 544, eaay2578
DOI: 10.1126/scitranslmed.aay2578

Log in to view PDF

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine